Shedir Pharma Spa reported that it ended 2023 with consolidated revenues of EUR60.2 million, up 10 percent from EUR54.6 million as of Dec. 31, 2022. Consolidated net income in the period stood at.
Shedir Pharma Spa reported Friday that revenues in the first half of the year were EUR28.5 million, up 20 percent from EUR23.8 million in the same period last year. As of June 30, profit was EUR1.2.
Shedir Pharma Spa reported that it bought back 8,250 of its own ordinary shares between May 8 and 12. The shares were taken over at an average unit price of EUR4.592, for a total consideration of. | May 16, 2023
Shedir Pharma Spa announced Monday that it bought back 7,000 of its own ordinary shares between April 17 and April 21. The shares were taken over at an average unit price of EUR4.6620, for a total. | April 24, 2023
Shedir Pharma Spa announced Monday that it bought back 4,000 of its own ordinary shares between April 10 and April 14. The shares were taken over at an average unit price of EUR4.3090, for a total. | April 18, 2023